InvestorsHub Logo
Followers 6
Posts 216
Boards Moderated 0
Alias Born 05/19/2004

Re: ahab333 post# 970

Monday, 06/11/2018 11:29:23 AM

Monday, June 11, 2018 11:29:23 AM

Post# of 1450

AgeX sold at $2.50 a share.

We now seem to have Jim Mellon's stamp of approval and access to TWO Artificial Intelligence platforms to hopefully expedite and provide more efficacy to our research process.

There's abundant evidence of poor human decision making in the biotech world that I'm inclined to approve of the addition of machine intelligence decision making to the AgeX process.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LCTX News